WHY BLAME CHOLESTEROL? by Hawthorne, Victor M.
146
Netherlands and the U.S. while the "very strong smell" and
"acrid, pungent taste" (to quote the Oxford English Diction-
ary) of Allium sativum almost never contribute to the cookery
of rural Finland. All around the Mediterranean garlic is used
in abundance-in excess Britons might say-and in all that
region CHD is far less common than it is in Britain and north-
ern Europe where garlic is used timidly if at all. But there is
no lack of other parallel differences between the regions-wine
v. milk or beer, olive oil v. butter, small v. large portions of
meat, strong v. weak coffee or tea, masses of leafy vegetables
v.... you name it.
The development of atherosclerosis and the clinical disease
may be promoted or hindered by a host of things, known and
unknown, and simple associations, such as those with the use
of wine or garlic, warrant no conclusions about cause and
effect. At best it might be stated that the observed association
is or is not consistent with a certain hypothesis, a hypothesis
derived from a reasonable concept of pathogenesis and a clear
understanding of relevant facts of physiology and biochemis-
try. But in regard to wine and garlic the hypothesis is missing.
Most of the differences in the incidence of ischaemic heart-
disease among the cohorts of the Seven Countries Study are
accounted for by two variables-the concentration of choles-
terol in the serum and the arterial blood-pressure. Now if it
could be shown that the habit of drinking wine and/or eating
garlic lowers the serum cholesterol or the blood pressure, or
both, we could urge a campaign to use more wine and garlic.
I live much of the time in southern Italy and need no such per-
suasion happily to embrace the local customs of the kitchen
and the dinner table.
Laboratory of Physiological Hygiene,
School of Public Health,
University of Minnesota,
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WHY BLAME CHOLESTEROL?
SiR,&mdash; I he correspondence in your Dec. 1 issue again illus-
trates the fallacy and futility of attempting to attribute unifac-
torial causality to multifactorial disease. By failing to cite
smoking and blood-pressure among the "physical, chemical,
organismal, or perhaps immunological" factors involved in the
reaction of the vessel wall to injury and subsequent develop-
ment of cholesterol-containing, raised plaques, Sir John
McMichael ignores established fact. He also reveals something
of the contrived nature of his contentions by commenting on
high mortality in New Zealand Maoris with low cholesterol
while omitting any reference to blood-pressure, body-weight,
and smoking.
The Report of the Joint Working Party of the Royal College
of Physicians and the British Cardiological Society devoted
about a fifth of its content to lipids. It emphasised the variation
in CHD risk according to the total burden of risk factors and
the need to consider the overall degree of CHD risk rather
than whether any particular factor had reached a "critical"
level, when dealing with an individual. The same report
was unequivocal in stating that the cost of any of the preven-
tive measures recommended, including that of reducing satu-
rated fat and partly substituting polyunsaturated fat, did not
approach the cost of inaction.
In our own work in the West of Scotland,2,3 the independent
and significant nature of the relative and attributable risks in
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census identified populations of Renfrew and Paisley for CHD
mortality by the 80-95th and the top 5th percentile of baseline
cholesterol values, has already been described in an illustrative
sample of 5616 males observed over 5 years.4 No contrary evi-
dence has yet emerged.
Whatever the basis for the 8% decline and 12% increase in
CHD mortality between 1969 and 1973 in U.S. White males
age 45-54 years compared with England and Wales, North
Ireland, and Scotland, respectively,5,6 cholesterol is one of the
many factors contributing in varying degree to this disturbing
difference. We hope it will encourage others in U.K. to know
that a noteworthy inclusion in the fifteen programmes pro-
posed to prevent disease and promote health into the 1990s in
U.S., is one with the specific aim to reduce population choles-
terol levels to 180 mg/dl within this decade.7
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EXTRA CHROMOSOME 12 IN CHRONIC
LYMPHOCYTIC LEUK&AElig;MIA
SIR,-Polyclonal B cell mitogens can induce both DNA syn-
thesis and immunoglobulin production in lymphocytes from
patients with chronic lymphocytic leukxmia (CLL).1 We have
reported that stimulation with one such mitogen, the Epstein-
Barr virus (EBV), revealed a chromosomal aberration in a
CLL patient.2 We have now investigated eight patients with
this disease, seven of whom were untreated.
Peripheral blood lymphocytes were stimulated by EBV in all
patients. In seven of them another polyclonal B cell mitogen,
lipopolysaccharide from Escherichia coli (LPS), was also used
for stimulation. Metaphases were analysed after five days of
incubation. The Q-banding technique was used for chromo-
some identification.
Four of the patients had an extra chromosome 12 in more
than a third of the metaphases investigated, after stimulation
with EBV. Three of them had the same abnormality after sti-
mulation with LPS. Two of these patients had additional aber-
rations. One had a deletion of chromosome 2 and the other a
deletion of chromosome 14 (table).
The conclusion is that polyclonal B cell mitogens can stimu-
late CLL lymphocytes and reveal previously undetectable
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